These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 10440744

  • 1. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E, Moro D, Gazzeri S, Brambilla C.
    J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
    [Abstract] [Full Text] [Related]

  • 2. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.
    Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846
    [Abstract] [Full Text] [Related]

  • 3. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB, Lantuejoul S, Abbondanzo S, Chu WS, Hasleton PS, Travis WD, Brambilla E.
    Hum Pathol; 2003 Feb 15; 34(2):136-42. PubMed ID: 12612881
    [Abstract] [Full Text] [Related]

  • 4. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S, Isisag A, Saruc M, Nese N, Demir MA, Kucukmetin NT.
    Hepatogastroenterology; 2010 Feb 15; 57(98):251-6. PubMed ID: 20583423
    [Abstract] [Full Text] [Related]

  • 5. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T, Takahashi T.
    Clin Cancer Res; 1997 Jul 01; 3(7):1051-8. PubMed ID: 9815783
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC, Coffey DM, Gondo MM, Stephenson MA, Brown RW, Cagle PT.
    Mod Pathol; 2000 Nov 01; 13(11):1167-72. PubMed ID: 11106072
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S, Gouyer V, Vour'ch C, Brambilla C, Brambilla E.
    Oncogene; 1998 Jan 29; 16(4):497-504. PubMed ID: 9484839
    [Abstract] [Full Text] [Related]

  • 11. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue.
    Krecicki T, Smigiel R, Fraczek M, Kowalczyk M, Sasiadek MM.
    J Laryngol Otol; 2004 Sep 29; 118(9):676-80. PubMed ID: 15509364
    [Abstract] [Full Text] [Related]

  • 12. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
    Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C.
    Clin Cancer Res; 1999 Feb 29; 5(2):243-50. PubMed ID: 10037171
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
    Au NH, Cheang M, Huntsman DG, Yorida E, Coldman A, Elliott WM, Bebb G, Flint J, English J, Gilks CB, Grimes HL.
    J Pathol; 2004 Sep 29; 204(1):101-9. PubMed ID: 15307143
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S, Mihara M, Nakahara Y, Kiyota A, Yoshihama Y, Ueyama Y, Matsumura T.
    Anticancer Res; 2000 Sep 29; 20(3B):2169-75. PubMed ID: 10928172
    [Abstract] [Full Text] [Related]

  • 17. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D.
    Oncogene; 1999 Jun 10; 18(23):3541-5. PubMed ID: 10376532
    [Abstract] [Full Text] [Related]

  • 18. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
    Muirhead DM, Hoffman HT, Robinson RA.
    J Clin Pathol; 2006 Jul 10; 59(7):711-5. PubMed ID: 16467168
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cell cycle-related gene abnormalities and product expression in esophageal carcinoma.
    Roncalli M, Bosari S, Marchetti A, Buttitta F, Bossi P, Graziani D, Peracchia A, Bonavina L, Viale G, Coggi G.
    Lab Invest; 1998 Sep 10; 78(9):1049-57. PubMed ID: 9759649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.